Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function

References

• VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med201318734736522878278
   PubMed Web of Science ®Google Scholar
• Dal NegroRWBonadimanLTurcoPPrevalence of different comorbidities in COPD patients by gender and GOLD stageMultidiscip Respir Med2015102426246895
   PubMed Web of Science ®Google Scholar
• SinDDAnthonisenNRSorianoJBAgustiAGMortality in COPD: role of comorbiditiesEur Respir J2006281245125717138679
   PubMed Web of Science ®Google Scholar
• ISTH Steering Committee for World Thrombosis DayThrombosis: a major contributor to global disease burdenThromb Res201413493193825312343
   PubMed Web of Science ®Google Scholar
• CesariMPahorMIncalziRAPlasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditionsCardiovasc Ther201028e72e9120626406
   PubMed Web of Science ®Google Scholar
• LoskutoffDJSawdeyMMimuroJType 1 plasminogen activator inhibitorProg Hemost Thromb19899871152492381
   PubMedGoogle Scholar
• SobelBEIncreased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradoxCirculation1999992496249810330378
   PubMed Web of Science ®Google Scholar
• Juhan-VagueIPykeSDAlessiMCJespersenJHaverkateFThompsonSGFibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and DisabilitiesCirculation199694205720638901651
   PubMed Web of Science ®Google Scholar
• Juhan-VagueIAlessiMCMavriAMorangePEPlasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular riskJ Thromb Haemost200311575157912871293
   PubMed Web of Science ®Google Scholar
• YamamotoKTakeshitaKKojimaTTakamatsuJSaitoHAging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderlyCardiovasc Res20056627628515820196
   PubMed Web of Science ®Google Scholar
• CavaillesABrinchault-RabinGDixmierAComorbidities of COPDEur Respir Rev20132245447524293462
   PubMedGoogle Scholar
• ItoKBarnesPJCOPD as a disease of accelerated lung agingChest200913517318019136405
   PubMed Web of Science ®Google Scholar
• TapsonVFThe role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary diseaseProc Am Thorac Soc20052717716113472
   PubMedGoogle Scholar
• EssaESEl WahshRAAssociation between plasminogen activator inhibitor-1-675 4G/5G insertion/deletion polymorphism and chronic obstructive pulmonary diseaseCOPD20161375675927073968
   PubMedGoogle Scholar
• WangHYangTLiDElevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2016112369237627713627
   PubMed Web of Science ®Google Scholar
• WatzHWaschkiBBoehmeCClaussenMMeyerTMagnussenHExtrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional studyAm J Respir Crit Care Med200817774375118048807
   PubMed Web of Science ®Google Scholar
• WaschkiBKirstenAMHolzODisease progression and changes in physical activity in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201519229530626020495
   PubMed Web of Science ®Google Scholar
• WaschkiBKirstenAHolzOAngiopoietin-like protein 4 and cardiovascular function in COPDBMJ Open Respir Res20163e000161
   Google Scholar
• AlbertiKGZimmetPShawJThe metabolic syndrome–a new worldwide definitionLancet20053661059106216182882
   PubMed Web of Science ®Google Scholar
• WoutersEFAdiponectin: a novel link between adipose tissue and chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201318852252323992584
   PubMed Web of Science ®Google Scholar
• McMurrayJJAdamopoulosSAnkerSDESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEur J Heart Fail20121480386922828712
   PubMed Web of Science ®Google Scholar
• AboyansVCriquiMHAbrahamPMeasurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart AssociationCirculation20121262890290923159553
   PubMed Web of Science ®Google Scholar
• LibbyPTriglycerides on the rise: should we swap seats on the seesaw?Eur Heart J20153677477625548060
   PubMed Web of Science ®Google Scholar
• StrangFSchunkertHC-reactive protein and coronary heart disease: all said–is not it?Mediators Inflamm2014201475712324808639
   PubMed Web of Science ®Google Scholar
• CrutchleyDJMcPheeGVTerrisMFCanossa-TerrisMALevels of three hemostatic factors in relation to serum lipids. Monocyte procoagulant activity, tissue plasminogen activator, and type-1 plasminogen activator inhibitorArteriosclerosis198999349392511826
   PubMedGoogle Scholar
• AlessiMCJuhan-VagueIPAI-1 and the metabolic syndrome: links, causes, and consequencesArterioscler Thromb Vasc Biol2006262200220716931789
   PubMed Web of Science ®Google Scholar
• DahlMVestboJLangePBojesenSETybjaerg-HansenANordestgaardBGC-reactive protein as a predictor of prognosis in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200717525025517053205
   PubMed Web of Science ®Google Scholar
• FabbriLMRabeKFFrom COPD to chronic systemic inflammatory syndrome?Lancet200737079779917765529
   PubMed Web of Science ®Google Scholar
• TanniSEZamunerATCoelhoLSValeSAGodoyIPaivaSAAre metabolic syndrome and its components associated with 5-year mortality in chronic obstructive pulmonary disease patients?Metab Syndr Relat Disord201513525425353094
   PubMed Web of Science ®Google Scholar
• IdellSCoagulation, fibrinolysis, and fibrin deposition in acute lung injuryCrit Care Med200331S213S22012682443
   PubMed Web of Science ®Google Scholar
• KucharewiczIKowalKBuczkoWBodzenta-LukaszykAThe plasmin system in airway remodelingThromb Res20031121715013265
   PubMed Web of Science ®Google Scholar
• ParkJAFredbergJJDrazenJMPutting the squeeze on airway epitheliaPhysiology (Bethesda)20153029330326136543
   PubMed Web of Science ®Google Scholar
• GhoshAKVaughanDEPAI-1 in tissue fibrosisJ Cellular Physiol201222749350721465481
   PubMed Web of Science ®Google Scholar
• VassalliJDSappinoAPBelinDThe plasminogen activator/plasmin systemJ Clin Invest199188106710721833420
   PubMed Web of Science ®Google Scholar
• VisseRNagaseHMatrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistryCirc Res20039282783912730128
   PubMed Web of Science ®Google Scholar
• HoggJCMcDonoughJEGosselinkJVHayashiSWhat drives the peripheral lung-remodeling process in chronic obstructive pulmonary disease?Proc Am Thorac Soc2009666867220008873
   PubMedGoogle Scholar
• SchuligaMWestallGXiaYStewartAGThe plasminogen activation system: new targets in lung inflammation and remodelingCurr Opin Pharmacol20131338639323735578
   PubMed Web of Science ®Google Scholar
• BarnardSAPietersMDe LangeZThe contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levelsBlood Rev20163042142927233154
   PubMed Web of Science ®Google Scholar